BR0316467A - Composição e método para tratar nefrite de lúpus - Google Patents

Composição e método para tratar nefrite de lúpus

Info

Publication number
BR0316467A
BR0316467A BR0316467-5A BR0316467A BR0316467A BR 0316467 A BR0316467 A BR 0316467A BR 0316467 A BR0316467 A BR 0316467A BR 0316467 A BR0316467 A BR 0316467A
Authority
BR
Brazil
Prior art keywords
bflp1698
composition
lupus nephritis
treating lupus
polypeptide
Prior art date
Application number
BR0316467-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Margot Otoole
William M Mounts
Negin Shojaee
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BR0316467A publication Critical patent/BR0316467A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BR0316467-5A 2002-11-21 2003-11-21 Composição e método para tratar nefrite de lúpus BR0316467A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42806502P 2002-11-21 2002-11-21
PCT/US2003/037317 WO2004047740A2 (en) 2002-11-21 2003-11-21 Composition and method for treating lupus nephritis

Publications (1)

Publication Number Publication Date
BR0316467A true BR0316467A (pt) 2005-10-11

Family

ID=32393343

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0316467-5A BR0316467A (pt) 2002-11-21 2003-11-21 Composição e método para tratar nefrite de lúpus

Country Status (9)

Country Link
US (2) US20050119208A1 (enExample)
EP (1) EP1563056A4 (enExample)
JP (1) JP2006516191A (enExample)
CN (1) CN1738896A (enExample)
AU (1) AU2003295784B2 (enExample)
BR (1) BR0316467A (enExample)
CA (1) CA2504561A1 (enExample)
MX (1) MXPA05005284A (enExample)
WO (1) WO2004047740A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020226960A1 (en) 2019-05-03 2020-11-12 Dicerna Pharmaceuticals, Inc. Double-stranded nucleic acid inhibitor molecules with shortened sense strands

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137077A1 (en) * 2000-10-25 2002-09-26 Hopkins Christopher M. Genes regulated in activated T cells
EP1661986A1 (en) * 2000-11-17 2006-05-31 Nuvelo, Inc. Nucleic acids and polypeptides enocoded thereby that are member of the kallikrein gene familyNovel nucleic acids and polypeptides
US6743619B1 (en) * 2001-01-30 2004-06-01 Nuvelo Nucleic acids and polypeptides
CA2445366A1 (en) * 2001-04-27 2002-11-21 Incyte Genomics, Inc. Molecules for disease detection and treatment
CA2500687A1 (en) * 2002-10-02 2004-04-15 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor

Also Published As

Publication number Publication date
AU2003295784B2 (en) 2009-06-11
EP1563056A4 (en) 2005-12-28
EP1563056A2 (en) 2005-08-17
WO2004047740A3 (en) 2005-02-17
JP2006516191A (ja) 2006-06-29
US20050119208A1 (en) 2005-06-02
US7667020B2 (en) 2010-02-23
CA2504561A1 (en) 2004-06-10
WO2004047740A2 (en) 2004-06-10
CN1738896A (zh) 2006-02-22
US20080009008A1 (en) 2008-01-10
MXPA05005284A (es) 2005-07-25
AU2003295784A1 (en) 2004-06-18

Similar Documents

Publication Publication Date Title
BR0316476A (pt) Composição e processo para tratar nefrite do lúpus
WO2003000842A3 (en) Novel proteins and nucleic acids encoding same
WO2004000997A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003057158A3 (en) Method of treating apoptosis and compositions thereof
BRPI0507174A (pt) proteìnas de fusão hormÈnio-fc (fsh-fc) heterodiméricas estimuladoras de folìculo para o tratamento da infertilidade
WO2003080856A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
MXPA02008239A (es) Gen humano de la esquizofrenia.
WO2002081498A3 (en) Novel proteins and nucleic acids encoding same
WO2003010327A3 (en) Novel proteins and nucleic acids encoding same
WO2003040325A3 (en) Novel proteins and nucleic acids encoding same
MXPA03006218A (es) Receptor de citosina tipo 2 y acidos nucleicos que codifican para lo mismo.
BRPI0407031A (pt) Composições e métodos para tratamento de câncer empregando igsf9 e liv-1
WO2003083046A3 (en) Novel proteins and nucleic acids encoding same
WO2002072757A3 (en) Novel proteins and nucleic acids encoding same
WO2003078572A3 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
WO2003023001A3 (en) Novel proteins and nucleic acids encoding same
WO2003085124A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003064628A3 (en) Novel proteins and nucleic acids encoding same
WO2003025147A3 (en) Novel polynucleotides and proteins encoded thereby
WO2003029424A3 (en) Novel proteins and nucleic acids encoding same
WO2003102159A3 (en) Novel proteins and nucleic acids encoding same
WO2004047740A3 (en) Composition and method for treating lupus nephritis
WO2003040345A3 (en) Type 2 cytokine receptor and nucleic acids encoding same
WO2001090187A3 (en) G-protein coupled olfactory receptors
WO2002040539A3 (en) Gpcr-like protein and nucleic acids encoding same

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.